You are here

  • Home
  • Archive
  • Volume 16, Issue Suppl 3
  • 0268: Topoisomerase I (Top1) Amplifications and Deletions As a Predective Marker for Chemotherapy with Topotecan in Women with Advanced Ovarian Cancer (Oc)

Citation Tools

Article menu
ABSTRACT: Poster Session 1: Ovarian – Sunday, October 15, 2006
0268: Topoisomerase I (Top1) Amplifications and Deletions As a Predective Marker for Chemotherapy with Topotecan in Women with Advanced Ovarian Cancer (Oc)

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Spahn-Horn S, Ejlertsen B, Engelholm SA, et al
0268: Topoisomerase I (Top1) Amplifications and Deletions As a Predective Marker for Chemotherapy with Topotecan in Women with Advanced Ovarian Cancer (Oc)
International Journal of Gynecologic Cancer 2006;16:676-677.